Global lens on biotech innovation. Discover breakthrough pharmaceutical, dermatology, and health-tech startups reshaping medicine across 11 leading biotech hubs.
95+
Active Startups
11+
Countries
$46.8B
Funding Tracked
Explore groundbreaking biotech, pharmaceutical, dermatology, and health tech startups reshaping the future of medicine globally. From gene therapy breakthroughs to AI diagnostics, discover the innovations driving healthcare forward.
Meet the innovators transforming healthcare with cutting-edge solutions in biotech, pharmaceuticals, and medical technology.
Founded
2020
📍 Bengaluru, Karnataka, India
Biotech & Artificial Intelligence (TechBio)
immunitoAI is a TechBio company that leverages a proprietary generative AI platform to design novel antibody therapeutics from scratch. Its technology aims to make antibody discovery faster and more efficient by predicting drug-like properties before laboratory validation.
Founded
2024
📍 Marseille, France
Biopharmaceutical / Precision Oncology
Adcytherix is a biopharmaceutical company pioneering next-generation Antibody-Drug Conjugates (ADCs) to treat cancers with high unmet needs. Its proprietary "ADCX-Engine" focuses on novel payloads and linker architectures to overcome resistance and improve the safety of targeted cancer therapies.
Founded
2024
📍 Oxford, United Kingdom
TechBio / Drug Discovery (Neurodegeneration)
Scripta Therapeutics is an Oxford-based biotech company using AI and imaging to target transcription factors, the "master controllers" of gene expression. Its platform aims to reprogram diseased cells into healthy states to develop disease-modifying therapies for conditions like Alzheimer's and other neurodegenerative disorders.
Founded
2019
📍 Sacramento, California, USA
TechBio / AI-Driven Drug Discovery
DeepSeq.AI leverages a generative AI platform and high-throughput wet-lab assays to design optimized protein-based drugs. Its "explainable AI" approach focuses on modeling protein "grammar" to discover novel therapeutics with improved manufacturability and efficacy.
Hear directly from visionary healthcare entrepreneurs shaping the future of medicine and biotech innovation.
"Our goal is to enable faster and more accurate antibody discovery by leveraging AI to predict drug-like properties before laboratory validation, addressing the industry's biggest challenges in targeting undruggable diseases."
Dr. Aridni Shah
Co-Founder & CEO, immunitoAI
AI-Driven Antibody Discovery"We're building a leading ADC powerhouse with our proprietary ADCX-Engine, focusing on novel payloads and linker architectures to overcome resistance and transform cancer therapy for patients with high unmet needs."
Jack Elands
Founder & CEO, Adcytherix
Precision Oncology"By targeting transcription factors—the master controllers of gene expression—we aim to reprogram diseased cells into healthy states, developing true disease-modifying therapies for neurodegeneration."
Scripta Therapeutics Team
Leadership, Scripta Therapeutics
Neurodegeneration"Our explainable AI approach models protein grammar to discover novel therapeutics with improved manufacturability and efficacy, bridging the gap between computational predictions and real-world drug development."
DeepSeq.AI Team
Leadership, DeepSeq.AI
Protein-Based DrugsStay informed with the most impactful medical discoveries and innovations happening right now.
🏢 Guardant Health
Shield detects 83% of cancers - Less invasive screening alternative
From
USA
🏢 FDA Approval
First CRISPR-based cure correcting faulty hemoglobin genes
From
USA
🏢 Quibim
Virtual biopsies using 10M+ anonymized medical images on Azure
From
Spain
🏢 Research Breakthrough
Early detection enabling intervention years before symptoms
From
USA
🏢 Cera Care
Predictive AI forecasts 80% of health risks - $150M funding at $1B valuation
From
United Kingdom
Join our community of healthcare innovators, entrepreneurs, and industry leaders. Let's shape the future of medicine together.
pharmalenz@gmail.com
500+ Health Tech Hubs Globally
Follow us on LinkedIn & Twitter